Lv4
500 积分 2024-07-10 加入
Prevalence and Trend of Biopsy-Proven IgA Nephropathy in China: A Systematic Review
3天前
求助中
Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network
4天前
已完结
Case Series: Effectiveness and Safety of Telitacicept in Chinese Patients With Primary Sjögren's Disease
4天前
已完结
Comparing the Efficacy and Safety of First-Line Treatments for Chronic Lymphocytic Leukemia: A Network Meta-Analysis
9天前
已完结
High-Risk MCL: Recognition and Treatment
11天前
已完结
High-Risk MCL: Recognition and Treatment
11天前
已关闭
Controversies in the management of mucinous ovarian tumors
17天前
已关闭
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial
19天前
已完结
Lifetime course of myasthenia gravis
25天前
已完结
Time to lymphoma treatment within 24 months in ‘watch and wait’ follicular lymphoma is associated with inferior outcomes: A multicentre analysis
26天前
已完结
皖公网安备34019202002308
